Monday – March 27
Earnings watch – Notable companies due to report include Carnival (CCL) and PVH (PVH). Citi has Carnival listed as one of its Catalyst Call Buy ideas on the expectation for a post-earnings rally.
Healthcare watch – Pharming Group N.V. (PHAR) has an FDA action date on Leniolisib on March 29. Emergent BioSolutions (EBS) has a Prescription Drug User Fee Act goal date of March 29. Emergent was the first company to submit a supplemental New Drug Application for OTC and received Priority Review by the FDA. If approved, NARCAN would be the first 4 mg naloxone nasal spray available OTC in the U.S. Cognition Therapeutics (CGTX) will present Phase 2 biomarker data on CT1812 for Mild-to-Moderate Alzheimer’s Disease at the AD/PD conference. BioMarin’s (BMRN) Biologics License Application for Roctavian is currently under review by the U.S. Food and Drug Administration with a PDUFA target action date of March 31
All day – International Game Technology (IGT) and Everi Holdings (EVRI) will be two of the more notable companies to showcase new technology at the Indian Gaming Tradeshow & Convention in San Diego.